SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 05/07/2019
Entire Document
 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     o

 

Securities registered pursuant to Section 12(b) of the Act:

 

     
Title of each class Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 PTX N/A